Lundbeck sues competitor for infringing on patent rights

Lundbeck and Otsuka are alleging that pharmaceutical firm Viatris’s proposed drug is in violation of eight patents.
Photo: Jens Dresling
Photo: Jens Dresling
by marketwire, translated by daniel pedersen

Pharmaceutical firm Lundbeck has filed a lawsuit in the US against Viatris for violating the patent protection of schizophrenia drug Abilify Maintena, Bloomberg News reports.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading